4-FLUOROBENZOIC ANHYDRIDE
-
4-FLUOROBENZOIC ANHYDRIDE
structure -
-
CAS No:
25569-77-1
-
Formula:
C14H8F2O3
-
Chemical Name:
4-FLUOROBENZOIC ANHYDRIDE
-
Synonyms:
4-FLUOROBENZOIC ANHYDRIDE;Bis(4-fluorobenzoic acid)anhydride;Bis[p-fluorobenzoic]anhydride;4-Fluorobenzoic acid anhydride with 4-fluorobenzoic acid;p-Fluorobenzoic anhydride
- Categories:
-
CAS No:
Characteristics
43.4
3.4
1.343g/cm3
107-108℃
178.9ºC
1.558
Sparingly soluble in water.(0.26 g/L) (25°C),
Safety Information
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501
H315
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
4-FLUOROBENZOIC ANHYDRIDE Use and Manufacturing
General procedure: TsCl (0.5 mmol, 0.10 g) was added to the mixture of carboxylic acid (1 mmol) and KA flame-dried 4.0 mL vial was charged with Pd(TFA)2 (9.9 mg, 0.03 mmol, 10 mol%), benzoquinone (3.3mg, 0.03 mmol, 10 mol%), CuI (17.1 mg, 0.09 mmol, 30 mol%), AsPh3 (27.6 mg, 0.09 mmol, 30 mol%), 1t(59.1mg, 0.3 mmol, 1.0 equiv, based on monomer) and substituted General procedure: A flame-dried 4.0 mL vial was charged with Pd(TFA)2 (9.9 mg, 0.03 mmol, 10 mol%), benzoquinone (3.3mg, 0.03 mmol, 10 mol%), CuI (17.1 mg, 0.09 mmol, 30 mol%), AsPh3 (27.6 mg, 0.09 mmol, 30 mol%), arylboroxine (0.3 mmol, 1.0 equiv, based on monomer) and substituted benzoic anhydride (0.6 mmol, 2.0equiv). The vial was directly transferred into a nitrogen-filled glovebox without caps. Then, K2CO3 (6.2 mg, 0.045 mmol, 15 mol%) and 4A molecular sieves (400 mg) were added. In another 4.0 mL vial, NBE (16.9mg, 0.18 mmol) was dissolved in 1.5 mL dry toluene. 0.5 mL of this NBE solution (5.64 mg, 0.06 mmol, 20mol%) was transferred into the reaction mixture, before another 3.5 mL dry toluene was added. The vialwas tightly sealed, transferred out of glovebox and stirred on a pie-block preheated to 100 oC for 14 hours.After completion of the reaction, the mixture was filtered through a thin pad of silica gel. The filter cakewas washed with ethyl acetate and the combined filtrate was concentrated. The residue was loaded to asmall amount of silica gel and then purified by flash column chromatography on silica gel to give thedesired ortho acylation product.General procedure: A flame-dried 4.0 mL vial was charged with Pd(TFA)2 (9.9 mg, 0.03 mmol, 10 mol%), benzoquinone (3.3mg, 0.03 mmol, 10 mol%), CuI (17.1 mg, 0.09 mmol, 30 mol%), AsPh3 (27.6 mg, 0.09 mmol, 30 mol%), arylboroxine (0.3 mmol, 1.0 equiv, based on monomer) and substituted benzoic anhydride (0.6 mmol, 2.0equiv). The vial was directly transferred into a nitrogen-filled glovebox without caps. Then, K2CO3 (6.2 mg, 0.045 mmol, 15 mol%) and 4A molecular sieves (400 mg) were added. In another 4.0 mL vial, NBE (16.9mg, 0.18 mmol) was dissolved in 1.5 mL dry toluene. 0.5 mL of this NBE solution (5.64 mg, 0.06 mmol, 20mol%) was transferred into the reaction mixture, before another 3.5 mL dry toluene was added. The vialwas tightly sealed, transferred out of glovebox and stirred on a pie-block preheated to 100 oC for 14 hours.After completion of the reaction, the mixture was filtered through a thin pad of silica gel. The filter cakewas washed with ethyl acetate and the combined filtrate was concentrated. The residue was loaded to asmall amount of silica gel and then purified by flash column chromatography on silica gel to give thedesired ortho acylation product.General procedure: A flame-dried 4.0 mL vial was charged with Pd(TFA)2 (9.9 mg, 0.03 mmol, 10 mol%), benzoquinone (3.3mg, 0.03 mmol, 10 mol%), CuI (17.1 mg, 0.09 mmol, 30 mol%), AsPh3 (27.6 mg, 0.09 mmol, 30 mol%), arylboroxine (0.3 mmol, 1.0 equiv, based on monomer) and substituted benzoic anhydride (0.6 mmol, 2.0equiv). The vial was directly transferred into a nitrogen-filled glovebox without caps. Then, K2CO3 (6.2 mg, 0.045 mmol, 15 mol%) and 4A molecular sieves (400 mg) were added. In another 4.0 mL vial, NBE (16.9mg, 0.18 mmol) was dissolved in 1.5 mL dry toluene. 0.5 mL of this NBE solution (5.64 mg, 0.06 mmol, 20mol%) was transferred into the reaction mixture, before another 3.5 mL dry toluene was added. The vialwas tightly sealed, transferred out of glovebox and stirred on a pie-block preheated to 100 oC for 14 hours.After completion of the reaction, the mixture was filtered through a thin pad of silica gel. The filter cakewas washed with ethyl acetate and the combined filtrate was concentrated. The residue was loaded to asmall amount of silica gel and then purified by flash column chromatography on silica gel to give thedesired ortho acylation product.General procedure: A flame-dried 4.0 mL vial was charged with Pd(TFA)2 (9.9 mg, 0.03 mmol, 10 mol%), benzoquinone (3.3mg, 0.03 mmol, 10 mol%), CuI (17.1 mg, 0.09 mmol, 30 mol%), AsPh3 (27.6 mg, 0.09 mmol, 30 mol%), arylboroxine (0.3 mmol, 1.0 equiv, based on monomer) and substituted benzoic anhydride (0.6 mmol, 2.0equiv). The vial was directly transferred into a nitrogen-filled glovebox without caps. Then, K2CO3 (6.2 mg, 0.045 mmol, 15 mol%) and 4A molecular sieves (400 mg) were added. In another 4.0 mL vial, NBE (16.9mg, 0.18 mmol) was dissolved in 1.5 mL dry toluene. 0.5 mL of this NBE solution (5.64 mg, 0.06 mmol, 20mol%) was transferred into the reaction mixture, before another 3.5 mL dry toluene was added. The vialwas tightly sealed, transferred out of glovebox and stirred on a pie-block preheated to 100 oC for 14 hours.After completion of the reaction, the mixture was filtered through a thin pad of silica gel. The filter cakewas washed with ethyl acetate and the combined filtrate was concentrated. The residue was loaded to asmall amount of silica gel and then purified by flash column chromatography on silica gel to give thedesired ortho acylation product.General procedure: A flame-dried 4.0 mL vial was charged with Pd(TFA)2 (9.9 mg, 0.03 mmol, 10 mol%), benzoquinone (3.3mg, 0.03 mmol, 10 mol%), CuI (17.1 mg, 0.09 mmol, 30 mol%), AsPh3 (27.6 mg, 0.09 mmol, 30 mol%), arylboroxine (0.3 mmol, 1.0 equiv, based on monomer) and substituted benzoic anhydride (0.6 mmol, 2.0equiv). The vial was directly transferred into a nitrogen-filled glovebox without caps. Then, K2CO3 (6.2 mg, 0.045 mmol, 15 mol%) and 4A molecular sieves (400 mg) were added. In another 4.0 mL vial, NBE (16.9mg, 0.18 mmol) was dissolved in 1.5 mL dry toluene. 0.5 mL of this NBE solution (5.64 mg, 0.06 mmol, 20mol%) was transferred into the reaction mixture, before another 3.5 mL dry toluene was added. The vialwas tightly sealed, transferred out of glovebox and stirred on a pie-block preheated to 100 oC for 14 hours.After completion of the reaction, the mixture was filtered through a thin pad of silica gel. The filter cakewas washed with ethyl acetate and the combined filtrate was concentrated. The residue was loaded to asmall amount of silica gel and then purified by flash column chromatography on silica gel to give thedesired ortho acylation product.
Computed Properties
Molecular Weight:262.21
XLogP3:3.4
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:4
Exact Mass:262.04415044
Monoisotopic Mass:262.04415044
Topological Polar Surface Area:43.4
Heavy Atom Count:19
Complexity:298
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Dichlorophthalic anhydride
52005-46-6
-
DIANISOYL-L-TARTARIC ANHYDRIDE
50685-51-3
-
Benzoic acid, anhydride with acetic acid
2819-08-1
-
Glycine, anhydride with 5′-adenylic acid (1:1) Formula
35985-26-3
-
(2-METHYL-2-PROPEN-1-YL)SUCCINIC ANHYDRIDE Formula
18908-20-8
-
DL-2,3-DIPHENYL-SUCCINIC ACID ANHYDRIDE Formula
101278-21-1
-
4-Thiazoleacetic acid, 2-amino-α-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-, anhydride with O,O-diethyl hydrogen phosphorothioate, (Z)- Structure
162208-28-8
-
BENZYL BUTANEDIOIC ACID ANHYDRIDE Structure
22884-81-7
-
What is Carbamic acid, diethyl-, anhydride with methanesulfenic acid (9CI)
552283-13-3
-
What is Butanoic acid, 2-nitro-, anhydride with hypofluorous acid (9CI)
125973-30-0